BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31402560)

  • 1. miR-367 as a therapeutic target in stem-like cells from embryonal central nervous system tumors.
    Kaid C; Jordan D; Bueno HMS; Araujo BHS; Assoni A; Okamoto OK
    Mol Oncol; 2019 Dec; 13(12):2574-2587. PubMed ID: 31402560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High OCT4A levels drive tumorigenicity and metastatic potential of medulloblastoma cells.
    da Silva PBG; Teixeira Dos Santos MC; Rodini CO; Kaid C; Pereira MCL; Furukawa G; da Cruz DSG; Goldfeder MB; Rocha CRR; Rosenberg C; Okamoto OK
    Oncotarget; 2017 Mar; 8(12):19192-19204. PubMed ID: 28186969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microrna expression signatures predict patient progression and disease outcome in pediatric embryonal central nervous system neoplasms.
    Braoudaki M; Lambrou GI; Giannikou K; Milionis V; Stefanaki K; Birks DK; Prodromou N; Kolialexi A; Kattamis A; Spiliopoulou CA; Tzortzatou-Stathopoulou F; Kanavakis E
    J Hematol Oncol; 2014 Dec; 7():96. PubMed ID: 25551588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zika Virus Selectively Kills Aggressive Human Embryonal CNS Tumor Cells
    Kaid C; Goulart E; Caires-Júnior LC; Araujo BHS; Soares-Schanoski A; Bueno HMS; Telles-Silva KA; Astray RM; Assoni AF; Júnior AFR; Ventini DC; Puglia ALP; Gomes RP; Zatz M; Okamoto OK
    Cancer Res; 2018 Jun; 78(12):3363-3374. PubMed ID: 29700002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel C19MC amplified cell line links Lin28/let-7 to mTOR signaling in embryonal tumor with multilayered rosettes.
    Spence T; Perotti C; Sin-Chan P; Picard D; Wu W; Singh A; Anderson C; Blough MD; Cairncross JG; Lafay-Cousin L; Strother D; Hawkins C; Narendran A; Huang A; Chan JA
    Neuro Oncol; 2014 Jan; 16(1):62-71. PubMed ID: 24311633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated microRNA-130b-5p or silenced ELK1 inhibits self-renewal ability, proliferation, migration, and invasion abilities, and promotes apoptosis of cervical cancer stem cells.
    Huang Y; Luo F
    IUBMB Life; 2021 Jan; 73(1):118-129. PubMed ID: 33295145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted serum miRNA (TSmiR) test for diagnosis and follow-up of (testicular) germ cell cancer patients: a proof of principle.
    Gillis AJ; Rijlaarsdam MA; Eini R; Dorssers LC; Biermann K; Murray MJ; Nicholson JC; Coleman N; Dieckmann KP; Belge G; Bullerdiek J; Xu T; Bernard N; Looijenga LH
    Mol Oncol; 2013 Dec; 7(6):1083-92. PubMed ID: 24012110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA-binding protein IGF2BP2 enhances circ_0000745 abundancy and promotes aggressiveness and stemness of ovarian cancer cells via the microRNA-3187-3p/ERBB4/PI3K/AKT axis.
    Wang S; Li Z; Zhu G; Hong L; Hu C; Wang K; Cui K; Hao C
    J Ovarian Res; 2021 Nov; 14(1):154. PubMed ID: 34774079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of miR-200 inhibition of Suz12 leads to polycomb-mediated repression required for the formation and maintenance of cancer stem cells.
    Iliopoulos D; Lindahl-Allen M; Polytarchou C; Hirsch HA; Tsichlis PN; Struhl K
    Mol Cell; 2010 Sep; 39(5):761-72. PubMed ID: 20832727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-199a-5p represses the stemness of cutaneous squamous cell carcinoma stem cells by targeting Sirt1 and CD44ICD cleavage signaling.
    Lu RH; Xiao ZQ; Zhou JD; Yin CQ; Chen ZZ; Tang FJ; Wang SH
    Cell Cycle; 2020 Jan; 19(1):1-14. PubMed ID: 31809227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF-κB maintains the stemness of colon cancer cells by downregulating miR-195-5p/497-5p and upregulating MCM2.
    Wang L; Guo J; Zhou J; Wang D; Kang X; Zhou L
    J Exp Clin Cancer Res; 2020 Oct; 39(1):225. PubMed ID: 33109220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of MYPT1 increases tumor resistance in ovarian cancer by targeting the Hippo pathway and increasing the stemness.
    Muñoz-Galván S; Felipe-Abrio B; Verdugo-Sivianes EM; Perez M; Jiménez-García MP; Suarez-Martinez E; Estevez-Garcia P; Carnero A
    Mol Cancer; 2020 Jan; 19(1):7. PubMed ID: 31926547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-30a suppresses self-renewal and tumorigenicity of glioma stem cells by blocking the NT5E-dependent Akt signaling pathway.
    Peng L; Ming Y; Zhang L; Zhou J; Xiang W; Zeng S; He H; Chen L
    FASEB J; 2020 Apr; 34(4):5128-5143. PubMed ID: 32067282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-942 promotes cancer stem cell-like traits in esophageal squamous cell carcinoma through activation of Wnt/β-catenin signalling pathway.
    Ge C; Wu S; Wang W; Liu Z; Zhang J; Wang Z; Li R; Zhang Z; Li Z; Dong S; Wang Y; Xue Y; Yang J; Tan Q; Wang Z; Song X
    Oncotarget; 2015 May; 6(13):10964-77. PubMed ID: 25844602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumorigenicity of cancer stem-like cells derived from hepatocarcinoma is regulated by microRNA-145.
    Jia Y; Liu H; Zhuang Q; Xu S; Yang Z; Li J; Lou J; Zhang W
    Oncol Rep; 2012 Jun; 27(6):1865-72. PubMed ID: 22378186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteome and miRNome profiling of microvesicles derived from medulloblastoma cell lines with stem-like properties reveals biomarkers of poor prognosis.
    Kaid C; Assoni A; Marçola M; Semedo-Kuriki P; Bortolin RH; Carvalho VM; Okamoto OK
    Brain Res; 2020 Mar; 1730():146646. PubMed ID: 31917138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-372 and miR-373 enhance the stemness of colorectal cancer cells by repressing differentiation signaling pathways.
    Wang LQ; Yu P; Li B; Guo YH; Liang ZR; Zheng LL; Yang JH; Xu H; Liu S; Zheng LS; Zhou H; Qu LH
    Mol Oncol; 2018 Nov; 12(11):1949-1964. PubMed ID: 30171794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific detection of OCT3/4 isoform A/B/B1 expression in solid (germ cell) tumours and cell lines: confirmation of OCT3/4 specificity for germ cell tumours.
    Rijlaarsdam MA; van Herk HA; Gillis AJ; Stoop H; Jenster G; Martens J; van Leenders GJ; Dinjens W; Hoogland AM; Timmermans M; Looijenga LH
    Br J Cancer; 2011 Sep; 105(6):854-63. PubMed ID: 21847120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA SPRY4-IT1 regulates breast cancer cell stemness through competitively binding miR-6882-3p with TCF7L2.
    Song X; Zhang X; Wang X; Chen L; Jiang L; Zheng A; Zhang M; Zhao L; Wei M
    J Cell Mol Med; 2020 Jan; 24(1):772-784. PubMed ID: 31736268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway.
    Liu YM; Cao Y; Zhao PS; Wu LY; Lu YM; Wang YL; Zhao JF; Liu XG
    Int J Biol Sci; 2022; 18(2):637-651. PubMed ID: 35002514
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.